Michigan State University
msu.eduTotal trials
139
Active
35
Phase 3
4
Total enrollment
590,255
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Osteopathic Manipulative Therapy and Exercise Therapy | — | — | — | — | — | 1 |
Next readouts
- 2025-04-07
Top conditions
- Stress5
- Anxiety5
- Cancer4
- Obesity4
- Breast Cancer4
- Autism Spectrum Disorder4
- Functional Abdominal Pain Syndrome3
- Depression3
Frequently asked questions about Michigan State University
- How many clinical trials does Michigan State University have on ClinicalTrials.gov?
- Michigan State University is listed as the lead sponsor on 139 clinical trials in ClinicalTrials.gov, 35 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Michigan State University's trials are in Phase 3?
- 4 of Michigan State University's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Michigan State University focus on?
- Michigan State University's most-studied conditions on ClinicalTrials.gov are Stress, Anxiety, Cancer, Obesity, Breast Cancer.
- When are Michigan State University's next clinical trial readouts?
- Michigan State University has 1 upcoming primary-completion readout tracked here; the soonest is “Treating Chronic Cervicogenic Head and Neck Pain”, expected around 2025-04-07.